百晓学者学者目录

刘婕

助理教授、博士生导师、硕士生导师，厦门大学

精选作品

期刊论文

2026

大麻二酚纳米晶口腔黏膜给药制剂的制备及体内外研究

刘婕，陈曦蕊，王富畅，王永军，张永国

《沈阳药科大学学报》

2025

A genome-wide screen identified ARHGAP35 as a regulator of regorafenib resistance in liver cancer

Kun Chen, Miaomiao Zhang, Yuexin Liu, Zhengnan Dong, Yaoji Liang, Jin-Zhang Zeng, Jie Liu

Anti-Cancer Drugs

DOI

2024

Modulation of TNFR 1-Triggered Inflammation and Apoptosis Signals by Jacaranone in Cancer Cells

Jie Liu, Yang Xu, Guobin Xie, Bingjie Geng, Renjing Yang, Wenjing Tian, Haifeng Chen, Guanghui Wang

International Journal of Molecular Sciences

DOI

2023

基于网络毒理学和代谢组学的青蒿琥酯心脏毒性作用机制研究

陈璐璐，袁祯爽，刘婕，马瑜瑾，江涛，李映，姜宏卫

《世界科学技术-中医药现代化》

2023

Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity

L. Ji, Jie Liu, Zhi-Jin Xu, Zhiqi Wei, Ruya Zhang, Seema Malkani, N. Cater, R. Frederich

Diabetes Therapy

DOI

2023

A Phase 2a active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with nonalcoholic fatty liver disease.

M. Romero-Gómez, E. Lawitz, R. Shankar, E. Chaudhri, Jie Liu, Raymond L. H. Lam, K. Kaufman, S. Engel

Journal of Hepatology

DOI

2023

Consensus of Chinese experts on strengthening personalized prevention and treatment of type 2 diabetes.

Bin Lu, Jian-Qing Sun, Li-Li Chen, Xiao-Yan Song, Yan-Hong Deng, Yan-Hu Dong, Ji-Xiang Dong, Pei-Yi Du, J. Ge, Yong-le Guo, P. Han, L. Ji, Qiang Li, Yuzhong Li, Chao Liu, Jing Liu, Jie Liu, Ju-Ming Lu, Xuan-jiang Shen, Limei Wan, Zhili Wang, Quan-Sheng Wang, Sen Wu, Ming-shuo Xu, Yan-Cheng Xu, Yaoming Xue, Chun Yuan, Yu-Zhi Yang, F. Zheng, Guo-Jin Zhuo, Lei Zhang, Qiu-Hua Zhang, Shu-Qi Zhu, Zhigang Zhao, J. Weng, Da-Long Zhu, R. Hu

Primary Care Diabetes

DOI

2023

Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV

S. Dagogo-Jack, R. Frederich, Jie Liu, C. Cannon, Harry Shi, D. Cherney, F. Cosentino, Urszula Masiukiewicz, I. Gantz, R. Pratley

Journal of Clinical Endocrinology and Metabolism

DOI

2023

Cardiorenal outcomes, kidney function, and other safety outcomes with ertugliflozin in older adults with type 2 diabetes (VERTIS CV): secondary analyses from a randomised, double-blind trial.

R. Pratley, C. Cannon, D. Cherney, F. Cosentino, D. McGuire, M. Essex, D. Lawrence, P. L. Jones, Jie Liu, I. Adamsons, S. Dagogo-Jack

The Lancet Healthy Longevity

DOI

2022

清肺化痰汤对OVA诱导的哮喘小鼠中Clara细胞向杯状细胞化生的影响

屈飞，黄俊浩，席超，张明月，刘婕，王心怡，曾杰，崔艳茹

《中药药理与临床》

2022

氯喹联合顺铂对结肠癌HCT116细胞的增殖和凋亡的影响

周静，张配，葛少波，刘婕，张杰

《中国临床药理学杂志》

2022

The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CV

D. Cherney, F. Cosentino, R. Pratley, S. Dagogo-Jack, R. Frederich, M. Maldonado, Jie Liu, A. Pong, Chih-Chin Liu, C. Cannon

Diabetes, obesity and metabolism

DOI

2022

Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium‐glucose cotransporter‐2 inhibitor ertugliflozin

K. Corbin, S. Dagogo-Jack, C. Cannon, D. Cherney, F. Cosentino, R. Frederich, Jie Liu, A. Pong, Jianxin Lin, N. Cater, R. Pratley

Diabetes, obesity and metabolism

DOI

2022

865-P: Long-Term Ertugliflozin Treatment and Incidence of Hypoglycemia: Analyses from VERTIS CV

S. Dagogo-Jack, C. Cannon, D. Cherney, F. Cosentino, D. McGuire, Jie Liu, Chih-Chin Liu, R. Frederich, J. Mancuso, R. Pratley

Diabetes

DOI

2022

Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV

S. Dagogo-Jack, C. Cannon, D. Cherney, F. Cosentino, Jie Liu, A. Pong, I. Gantz, R. Frederich, J. Mancuso, R. Pratley

Diabetes, obesity and metabolism

DOI

2022

Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes

Matthew W. Segar, A. Kolkailah, R. Frederich, A. Pong, C. Cannon, F. Cosentino, S. Dagogo-Jack, D. McGuire, R. Pratley, Chih-Chin Liu, M. Maldonado, Jie Liu, N. Cater, A. Pandey, D. Cherney

Diabetes, obesity and metabolism

DOI

2021

Design, synthesis, and biological evaluation of quinazolin-4(3H)-one derivatives co-targeting poly (ADP-ribose) polymerase-1 and bromodomain containing protein 4 for breast cancer therapy

Xiaosa Changy, Dejuan Suny, Danfeng Shiy, Guan Wang, Yanmei Chen, Kai Zhang, Huidan Tan, Jie Liu, Bo Liu, Liang Ouyang

Acta Pharmaceutica Sinica B

2021

Metal-organic frameworks for advanced drug delivery

Siyu He, Li Wu, Xue Li, Hongyu Sun, Ting Xiong, Jie Liu, Chengxi Huang, Huipeng Xu, Huimin Sun, Weidong Chen, Ruxandra Gref, Jiwen Zhang

Acta Pharmaceutica Sinica B

2021

CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics

Jian Lu, Jie Liu, Yuanqing Guo, Yuanjin Zhang, Yeye Xu, Xin Wang

Acta Pharmaceutica Sinica B

2021

Development of small-molecule tropomyosin receptor kinase(TRK) inhibitors for NTRK fusion cancers

Tingting Jiang, Guan Wang, Yao Liu, Lu Feng, Meng Wang, Jie Liu, Yi Chen, Liang Ouyang

Acta Pharmaceutica Sinica B

2021

785-P: Ertugliflozin (ERTU) Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients with Type 2 Diabetes (T2D): An Analysis From VERTIS CV

S. Dagogo-Jack, R. Frederich, B. Charbonnel, Jie Liu, C. Cannon, Harry Shi, D. McGuire, D. Cherney, F. Cosentino, W. Shih, Urszula Masiukiewicz, I. Gantz, R. Pratley

Diabetes

DOI

2021

783-P: Cardiorenal Outcomes with Ertugliflozin by Baseline (BL) Glucose-Lowering Agent (GLA): An Analysis from VERTIS CV

B. Charbonnel, S. Dagogo-Jack, C. Cannon, D. Cherney, F. Cosentino, D. McGuire, W. Shih, Jie Liu, A. Pong, I. Gantz, R. Frederich, J. Mancuso, R. Pratley

Diabetes

DOI

2021

Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy

I. Lingvay, Michelle Greenberg, Silvina Gallo, Harry Shi, Jie Liu, I. Gantz

Diabetes, obesity and metabolism

DOI

2021

786-P: Glycemic Efficacy and Safety of Ertugliflozin (ERTU) in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease Stage 3 (CKD 3): An Analysis from VERTIS CV

S. Dagogo-Jack, R. Pratley, D. Cherney, B. Charbonnel, D. McGuire, F. Cosentino, W. Shih, Jie Liu, R. Frederich, J. Mancuso, A. Raji, I. Gantz

Diabetes

DOI

2021

Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study

L. Ji, Yinghong Du, Min Xu, Xiangjun Zhou, Zhaohui Mo, Jianhua Ma, Jia-Rui Li, Yufeng Li, Jingna Lin, Yanjun Wang, Jing Yang, Wei-Hong Song, Hui Jin, S. Pang, Hui Liu, Ping Li, Jie Liu, Min-xue Yao, Wenhui Li, Xiaohong Jiang, Fei-Xia Shen, Hou-Fa Geng, Hai-Qi Zhou, J. Ran, Minxiang Lei, Yinghong Du, Shan-Dong Ye, Qingbo Guan, Wen-Shan Lv, Hui-Wen Tan, Tao Chen, Jin-Kui Yang, G. Qin, Shiyun Li, Lei Chen

Diabetologia

DOI

2021

Associations Between Obesity and Kidney Disease in Chinese Men and Women With Type 2 Diabetes: A Retrospective Cohort Study.

Yang-Yang Xia, Chun-Ming Jiang, Jing Lu, Jie Liu, T. Gu, Y. Bi

Canadian Journal of Diabetes

DOI

2021

Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV

M. Budoff, T. Davis, A. Palmer, R. Frederich, D. Lawrence, Jie Liu, I. Gantz, G. Derosa

Diabetes Therapy

DOI

2021

Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV

K. Strojek, A. Pandey, V. Dell, Melanie Sisson, Shuai Wang, S. Huyck, Jie Liu, I. Gantz

Diabetes Therapy

DOI

2021

Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial

S. Dagogo-Jack, R. Pratley, D. Cherney, D. McGuire, F. Cosentino, W. Shih, Jie Liu, R. Frederich, J. Mancuso, A. Raji, I. Gantz

BMJ Open Diabetes Research & Care

DOI

2021

Performance Evaluation of the Glunovo® Continuous Blood Glucose Monitoring System in Chinese Participants with Diabetes: A Multicenter, Self-Controlled Trial

R. Meng, T. Gu, Fan Yang, Jie Liu, Qi-Chao Sun, Da-Long Zhu

Diabetes Therapy

DOI

2021

Ertugliflozin and Slope of Chronic eGFR

D. Cherney, F. Cosentino, S. Dagogo-Jack, D. McGuire, R. Pratley, R. Frederich, M. Maldonado, Chih-Chin Liu, Jie Liu, A. Pong, C. Cannon

American Society of Nephrology. Clinical Journal

DOI

2021

Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy

Jie Liu, Jing Zhang, Mingdong Hou, Weiguo Du

Pakistan Journal of Medical Sciences

DOI

2021

Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study

L. Ji, Yinghong Du, Min Xu, Xiangjun Zhou, Zhaohui Mo, Jianhua Ma, Jia-Rui Li, Yufeng Li, Jingna Lin, Yanjun Wang, Jing Yang, Wei-Hong Song, Hui Jin, S. Pang, Hui Liu, P. Li, Jie Liu, Min-xue Yao, Wenhui Li, Xiaohong Jiang, Fei-Xia Shen, Hou-Fa Geng, Hai-Qi Zhou, J. Ran, Minxiang Lei, Yinghong Du, Shan-Dong Ye, Qingbo Guan, Wen-Shan Lv, Hui-Wen Tan, Tao Chen, Jin-Kui Yang, G. Qin, Shiyun Li, Lei Chen

Diabetologia

DOI

2021

Kidney outcomes using a sustained ≥40% decline in eGFR: A meta‐analysis of SGLT2 inhibitor trials

D. Cherney, S. Dagogo-Jack, D. McGuire, F. Cosentino, R. Pratley, W. Shih, R. Frederich, M. Maldonado, Jie Liu, Shuai Wang, C. Cannon

Clinical Cardiology

DOI

2021

791-P: Ertugliflozin in Older Patients with Type 2 Diabetes (T2D): An Analysis from VERTIS CV

R. Pratley, S. Dagogo-Jack, B. Charbonnel, D. Cherney, F. Cosentino, D. McGuire, M. Essex, P. L. Jones, Jie Liu, I. Adamsons, D. Lawrence, W. Shih, C. Cannon

Diabetes

DOI

2020

作用于polo-box结构域的拟肽类polo样激酶1抑制剂的设计、合成及其生物活性

李芝艳，刘婕，李冰艳，江程

《中国药科大学学报》

2020

清肺化痰汤通过抑制EGFR通路下调MUC5AC的表达治疗COPD的研究

屈飞，吴汉松，邱沙英，张明月，黄俊浩，曾杰，刘婕，崔艳茹

《中药药理与临床》

DOI

2020

Assessment of the efficacy of α-lipoic acid in treatment of diabetes mellitus patients with erectile dysfunction

Jia-Wei Cai, Jun-Min Chen, Qianqian Zeng, Jie Liu, Yan-Li Zhang, Haiping Cheng, Shasha Yao, Qiu Chen

Medicine

DOI

2020

Efficacy of vitamin D supplement in children with nonalcoholic fatty liver disease

Jie Liu, Tingting Wang, Jun-Min Chen, Yan-Li Zhang, Xiaoqing Yin, Xueqin Fan, Qiu Chen

Medicine

DOI

2020

Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studies

R. Pratley, S. Dagogo-Jack, B. Charbonnel, Shrita M. Patel, A. Hickman, Jie Liu, L. Tarasenko, A. Pong, M. Ellison, S. Huyck, I. Gantz, S. Terra

Diabetes, obesity and metabolism

DOI

2020

A protocol for systematic review and meta-analysis

Jie Liu, Tingting Wang, Jun-Min Chen, Yan-Li Zhang, Xiaoqing Yin, Xueqin Fan, Qiu Chen

2020

Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials

D. Cherney, H. Heerspink, R. Frederich, M. Maldonado, Jie Liu, A. Pong, Z. Xu, Shrita M. Patel, A. Hickman, J. Mancuso, I. Gantz, S. Terra

Diabetologia

DOI

2020

Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus

S. Heymsfield, A. Raji, Silvina Gallo, Jie Liu, A. Pong, Hakima Hannachi, S. Terra

Obesity

DOI

2020

Vitamin D Supplement for Prevention of Alzheimer's Disease: A Systematic Review and Meta-Analysis

Ya-ge Du, Fangfang Liang, Li-Ping Zhang, Jie Liu, Hao-ying Dou

American Journal of Therapeutics

DOI

2020

Efficacy and safety of ertugliflozin across racial groups in patients with type 2 diabetes mellitus

Jie Liu, L. Tarasenko, A. Pong, S. Huyck, Larry Wu, Shrita M. Patel, A. Hickman, J. Mancuso, I. Gantz, S. Terra

Current Medical Research and Opinion

DOI

2020

Systematic review and meta-analysis of vitamin D supplementation in the treatment of type 2 diabetic microangiopathy

Jun-Min Chen, Xiayu Gong, Jie Liu, Tingting Wang, Xiao-Yan Shi, Xiao-Ran Zhang, Qiu Chen

DOI

2020

Efficacy and safety of ertugliflozin in Hispanic/Latino patients with type 2 diabetes mellitus

Jie Liu, L. Tarasenko, A. Pong, S. Huyck, Shrita M. Patel, A. Hickman, J. Mancuso, M. Ellison, I. Gantz, S. Terra

Current Medical Research and Opinion

DOI

2020

Gradient of Risk and Associations with Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function: Observations from VERTIS CV.

D. Cherney, D. McGuire, B. Charbonnel, F. Cosentino, R. Pratley, S. Dagogo-Jack, R. Frederich, M. Maldonado, Jie Liu, A. Pong, Chih-Chin Liu, C. Cannon

Circulation

DOI

2020

The Roles of GSK-3β in Regulation of Retinoid Signaling and Sorafenib Treatment Response in Hepatocellular Carcinoma

Shuaishuai Zhang, Weiwei Gao, Juan Tang, Huaifang Zhang, Yuqi Zhou, Jie Liu, Kun Chen, Fangzhou Liu, Wengang Li, Sally K. Y. To, Alice S.T. Wong, Xiao-kun Zhang, Hu Zhou, Jin-Zhang Zeng

Theranostics

DOI

2019

1197-P: Two-Year Effects of Ertugliflozin on Renal Function

D. Cherney, H. Heerspink, R. Frederich, M. Maldonado, A. Pong, Zhi-Jin Xu, Jie Liu, J. Mancuso, I. Gantz, S. Terra

Diabetes

DOI

2019

Identification of autoimmune type 1 diabetes and multiple organ‐specific autoantibodies in adult‐onset non‐insulin‐requiring diabetes in China: A population‐based multicentre nationwide survey

Yu-Fei Xiang, Gan Huang, Yaxi Zhu, X. Zuo, Xinyuan Liu, Qiong Feng, Xia Li, Tu-Bao Yang, Ju-Ming Lu, Z. Shan, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, J. Ge, Li-xiang Lin, Li Chen, Xiao-Hui Guo, Z. Zhao, Qiang Li, J. Weng, W. Jia, Zhen-Qi Liu, L. Ji, Wen-Ying Yang, R. Leslie, Zhi-Guang Zhou

Diabetes, obesity and metabolism

DOI

2019

1210-P: Pooled Analysis of the Safety and Efficacy of Ertugliflozin in the Elderly

R. Pratley, S. Dagogo-Jack, B. Charbonnel, Shrita M. Patel, M. A. Hickman, Jie Liu, L. Tarasenko, M. Ellison, I. Gantz, S. Terra

Diabetes

DOI

2019

Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studies

Jie Liu, L. Tarasenko, S. Terra, S. Huyck, Larry Wu, A. Pong, R. Calle, Silvina Gallo, A. Darekar, J. Mancuso

Diabetes & vascular disease research

DOI

2019

Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin

P. Hollander, Julie Hill, Jeremy R Johnson, Zhi-Wei Jiang, G. Golm, S. Huyck, S. Terra, J. Mancuso, S. Engel, Brett Lauring, Jie Liu

Current Medical Research and Opinion

DOI

2019

SAT-291 EFFECTS OF ERTUGLIFLOZIN ON UACR AND eGFR IN PATIENTS WITH TYPE 2 DIABETES (T2D) AND CKD STAGE 3

M. Maldonado, D. Cherney, R. Frederich, Jie Liu, A. Pong, J. Xu, S. Terra, G. Ira

Kidney International Reports

DOI

2019

FP485EFFECTS OF ERTUGLIFLOZIN TREATMENT OVER 2 YEARS ON MEASURES OF RENAL FUNCTION

H. Heerspink, D. Cherney, M. Maldonado, R. Frederich, A. Pong, Zhi-Jin Xu, Jie Liu, J. Mancuso, I. Gantz, S. Terra

Nephrology, Dialysis and Transplantation

DOI

2019

2353-PUB: Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)

Jie Liu, L. Tarasenko, M. Ellison, A. Pong, S. Huyck, J. Mancuso, S. Terra, I. Gantz

Diabetes

DOI

2019

Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials

Jie Liu, A. Pong, Silvina Gallo, A. Darekar, S. Terra

Cardiovascular Diabetology

DOI

2019

Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitus

Jie Liu, Shrita M. Patel, N. Cater, Larry Wu, S. Huyck, S. Terra, A. Hickman, A. Darekar, A. Pong, I. Gantz

Diabetes, obesity and metabolism

DOI

2018

EFFECTS OF ERTUGLIFLOZIN ON BLOOD PRESSURE AND PULSE RATE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Jie Liu, A. Pong, Silvina Gallo, A. Darekar, S. Terra, Brett Lauring

DOI

2018

Altering of FTO in the serum and livers of NAFLD patients : a correlation analysis

Jian-Jin Guo, Wei Ren, Xing Li, Guang-Xia Xi, Yuan-Bin Li, Linlin Gao, Jie Liu, D. Su

2018

A Pooled Analysis of the Efficacy and Safety of Ertugliflozin as Add-On Therapy to Metformin

R. Calle, Jie Liu, S. Huyck, Larry Wu, A. Pong, J. Mancuso, S. Terra, Brett Lauring

Diabetes

DOI

2018

Efficacy and Safety of Ertugliflozin across Racial Groups in Patients with Type 2 Diabetes Mellitus (T2DM)

Jie Liu, L. Tarasenko, A. Pong, S. Huyck, Larry Wu, J. Mancuso, S. Terra, Brett Lauring

Diabetes

DOI

2018

Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells

Weixia Xu, Pengjin Ge, Boning Niu, Xiao-kun Zhang, Jie Liu, Jingjing Xie

Journal of Colloid and Interface Science

DOI

2017

差示扫描量热技术在药剂学中的应用进展

刘婕，杨丽，方亮

《中国药剂学杂志(网络版)》

2017

Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus

Hong-Hua Wu, Jie Liu, Qingqing Lou, Jing Liu, Li Shen, Ming-Xia Zhang, X. Lv, Ming-Jun Gu, Xiao-Hui Guo

Medicine

DOI

2017

The characteristics of newly diagnosed adult early-onset diabetes: a population-based cross-sectional study

Xian-Tong Zou, Xiang-Hai Zhou, L. Ji, Wen-Ying Yang, Ju-Ming Lu, J. Weng, W. Jia, Z. Shan, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, J. Ge, Li-xiang Lin, Li Chen, Xiao-Hui Guo, Z. Zhao, Qiang Li, Zhi-Guang Zhou

Scientific Reports

DOI

2017

A survey of Vitamin D level and the rate of Vitamin D supplementation in infants and young children in Tianjin

Jie Liu

DOI

2017

Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study

P. Hollander, Jie Liu, Julie Hill, Jeremy R Johnson, Zhi-Wei Jiang, G. Golm, S. Huyck, S. Terra, J. Mancuso, S. Engel, Brett Lauring

Diabetes Therapy

DOI

2017

Correlation between hyperhomocysteine and serum cystatin C in diabetic nephropathy

Jian-Jin Guo, Wei Ren, Xing Li, Guang-Xia Xi, Jie Liu

2017

Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo‐controlled randomized study

S. Dagogo-Jack, Jie Liu, R. Eldor, G. Amorin, Jeremy R Johnson, D. Hille, Y. Liao, S. Huyck, G. Golm, S. Terra, J. Mancuso, S. Engel, Brett Lauring

Diabetes, obesity and metabolism

DOI

2017

TNF-Alpha in Peripheral Neuropathy Patients with Impaired Glucose Regulation

Xia Li, Ju Zhu, Na Liu, Jie Liu, Zhe-Cheng Zhang

Journal of Diabetes Research

DOI

2017

The synergy of Helicobacter pylori and lipid metabolic disorders in induction of Th17-related cytokines in human gastric cancer

Jie Liu, Han Wang, Gang Chen, Mo Yang, Zhixian Wu, Russell Erick Ericksen, Alice S.T. Wong, Weiping Han, Jin-Zhang Zeng

Journal of Cancer Metastasis and Treatment

DOI

2016

Multiple organ-specific autoantibodies in patients with phenotypic type 2 diabetes in China: a post-hoc analysis of the China National Diabetes and Metabolic Disorders Study

Yu-Fei Xiang, Gan Huang, L. Ji, W. Jia, J. Weng, Ju-Ming Lu, Yaxi Zhu, Qiong Feng, Xia Li, Tu-Bao Yang, Zhen-Qi Liu, Z. Shan, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, J. Ge, Li-xiang Lin, Li Chen, Xiao-Hui Guo, Zhi-Gang Zhao, Qiang Li, X. Zuo, Xinyuan Liu, Wen-Ying Yang, Zhi-Guang Zhou

DOI

2016

Cigarette Smoking Is Associated with a Lower Prevalence of Newly Diagnosed Diabetes Screened by OGTT than Non-Smoking in Chinese Men with Normal Weight

Xu-Hong Hou, Jieyuzhen Qiu, Pei-Zhu Chen, Jun-xi Lu, Xiao-Jing Ma, Ju-Ming Lu, J. Weng, L. Ji, Z. Shan, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, J. Ge, Li-xiang Lin, Li Chen, Xiao-Hui Guo, Zhi-Gang Zhao, Qiang Li, Zhi-Guang Zhou, Wen-Ying Yang, W. Jia

PLoS ONE

DOI

2015

Association between Family History Risk Categories and Prevalence of Diabetes in Chinese Population

Jin-Ping Zhang, Zhao-Jun Yang, Jian-zhong Xiao, Xiao-Yan Xing, Ju-Ming Lu, J. Weng, W. Jia, L. Ji, Z. Shan, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, J. Ge, Li Chen, Xiao-Hui Guo, Z. Zhao, Qiang Li, Zhi-Guang Zhou, Li-xiang Lin, Na Wang, Wen-Ying Yang

PLoS ONE

DOI

2015

Weight‐neutral effect of once‐daily insulin detemir in Chinese type 2 diabetes patients: Subgroup analysis of the SOLVE study 一天一次地特胰岛素对中国2型糖尿病患者体重的中性影响：SOLVE研究亚组分析

C. Pan, P. Han, L. Ji, Q. Ji, Ju-Ming Lu, Jing Lin, Jie Liu, Ben-Li Su, Jing-Mei Shi, Peng-Hua Wang

Journal of Diabetes

DOI

2014

宝元灵对离体蛙心脏收缩功能的影响

刘婕，高虹，缪晓青

《华西药学杂志》

2014

每日一次地特胰岛素治疗65岁及以上老年2型糖尿病患者安全性和有效性的研究：SOLVE^TM国际临床观察研究中国结果报道

Zhang-Yu Pan, L. Ji, Ju-Ming Lu, Wen-Ying Yang, Zhi-Guang Zhou, D. Zou, Qiu-He Ji, P. Han, Jie Liu, Qiang Li

2014

Effectiveness of different waist circumference cut-off values in predicting metabolic syndrome prevalence and risk factors in adults in China.

Haiyan Zhou, Ya-Xin Lai, Yan-Shan Zhong, Wei Jia, Wen-Ying Yang, Ju-Ming Lu, Jian-Ping Weng, L. Ji, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, Li Chen, Xiao Hui Guo, Zhi-Gang Zhao, Qiang Li, Zhi-Guang Zhou, J. Ge, Liang-Shan Guang

Biomedical and environmental sciences : BES

DOI

2014

Efficacy of structured education in patients with type 2 diabetes mellitus receiving insulin treatment (结构化教育对接受胰岛素治疗的2型糖尿病患者的效果)

Xiao-Hui Guo, L. Ji, Ju-Ming Lu, Jie Liu, Qingqing Lou, Jing Liu, Li Shen, Ming-Xia Zhang, X. Lv, Ming-Jun Gu

Journal of Diabetes

DOI

2014

Obesity-Related Genomic Loci Are Associated with Type 2 Diabetes in a Han Chinese Population

Xiao-Mu Kong, Xuelian Zhang, Qi Zhao, Jiang He, Li Chen, Z. Zhao, Qiang Li, J. Ge, Gang Chen, Xiao-Hui Guo, Ju-Ming Lu, J. Weng, W. Jia, L. Ji, Jian-zhong Xiao, Z. Shan, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, Zhi-Guang Zhou, G. Shan, Wen-Ying Yang

PLoS ONE

DOI

2014

Associations between regional body fat distribution and homocysteine levels in type 2 diabetes with coronary atherosclerosis patients

Wei Ren, Jian-Jin Guo, Jie Liu

DOI

2014

BMI and waist circumference are associated with impaired glucose metabolism and type 2 diabetes in normal weight Chinese adults

Sheng-Xu Li, Jian-zhong Xiao, L. Ji, J. Weng, W. Jia, Ju-Ming Lu, Zhi-Guang Zhou, Xiao-Hui Guo, Jie Liu, Z. Shan, Da-Long Zhu, Li Chen, Z. Zhao, H. Tian, Q. Ji, J. Ge, Qiang Li, Li-xiang Lin, Zhao-Jun Yang, Jiang He, Wen-Ying Yang

Journal of diabetes and its complications

DOI

2014

Safety and effectiveness of biphasic insulin aspart 30 in both Chinese young and elderly patients with type 2 diabetes: results from the A1chieve study

Yu-Xiu Li, Xiao-Yan Xing, Jie Liu, Zheng-Nan Gao, B. Chang, Zhan-Jian Wang, Xiao-Ming Zhuang, Jing Hong, T. Yuan

DOI

2014

Biphasic insulin aspart 30 improved glycemic control in Chinese patients with type 2 diabetes poorly controlled on oral glucose‐lowering drugs: a subgroup analysis of the A1chieve study

L. Chen, Xiao-Yan Xing, Minxiang Lei, Jie Liu, Yong-Quan Shi, Peng-Qiu Li, G. Qin, Cheng-Jiang Li, Yukun Li, Qing Wang, T. Gao, Ling-Zi Hu, Yang-Wei Wang, Wen-Ying Yang

Chinese Medical Journal

DOI

2014

Abstract P235: Association of Lipid Related Genetic Variants and Hypertriglyceridemia in Type 2 Diabetic Patients from a Chinese Population

Xiao-Mu Kong, Xuelian Zhang, Qi Zhao, Jiang He, Li Chen, Z. Zhao, Qiang Li, J. Ge, Gang Chen, Xiao-Hui Guo, Ju-Ming Lu, J. Weng, W. Jia, L. Ji, Jian-zhong Xiao, Z. Shan, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, Zhi-Guang Zhou, G. Shan, Wen-Ying Yang

2014

Latent Autoimmune Diabetes in Adults With Low-Titer GAD Antibodies: Similar Disease Progression With Type 2 Diabetes

Ling-Jiao Liu, Xia Li, Yu-Fei Xiang, Gan Huang, Jian Lin, Lin Yang, Yun-Juan Zhao, Zhi-Fang Yang, C. Hou, Yi-Jun Li, Jie Liu, Da-Long Zhu, R. Leslie, Xiang-Bing Wang, Zhi-Guang Zhou

Diabetes Care

DOI

2014

中国老年和中青年糖尿病患者使用双时相门冬胰岛素30的疗效及安全性：来自 A1 chieve 研究结果

Yu-Xiu Li, Xiao-Yan Xing, Jie Liu, Zheng-Nan Gao, B. Chang, Zhan-Jian Wang, Xiao-Ming Zhuang, Jing Hong, Tao Yuan, Wen-Ying Yang

2014

Analysis of serum FTO level and related factors in obese and T2DM patients

Jian-Jin Guo, Wei Ren, Jie Liu, W. Jia

DOI

2013

Association of Genetic Variants with Isolated Fasting Hyperglycaemia and Isolated Postprandial Hyperglycaemia in a Han Chinese Population

Xiao-Mu Kong, Jing Hong, Ying Chen, Li Chen, Z. Zhao, Qiang Li, J. Ge, Gang Chen, Xiao-Hui Guo, Ju-Ming Lu, J. Weng, W. Jia, L. Ji, Jian-zhong Xiao, Z. Shan, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, Zhi-Guang Zhou, G. Shan, Wen-Ying Yang

PLoS ONE

DOI

2013

[The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents: the Chinese cohort from SOLVE(TM) observational study].

C. Pan, L. Ji, Ju-Ming Lu, Wen-ying Yang, Zhi-Guang Zhou, Da-jin Zou, Q. Ji, P. Han, Jie Liu, Qiang Li, Ben-li Su, Yan-Bing Li, Zheng-Nan Gao, Peng-Hua Wang, Shi-Nan Yin, Yan-hu Dong, Tao Yang, K. Sun, Hong Li, X. Hong, Jing Lin, Jing-Mei Shi, Xiao-jie Yang, Hui Fang, Xiao-dong Yan

Zhonghua nei ke za zhi

2013

Albuminuria: Prevalence, associated risk factors and relationship with cardiovascular disease

Fang Chen, Wen-Ying Yang, J. Weng, W. Jia, L. Ji, Jian-zhong Xiao, Z. Shan, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, J. Ge, Li-xiang Lin, Li Chen, Xiao-Hui Guo, Z. Zhao, Qiang Li, Zhi-Guang Zhou, G. Shan, Ju-Ming Lu

Journal of Diabetes Investigation

DOI

2013

Prevalence and associated factors of microalbuminuria in Chinese individuals without diabetes: cross-sectional study

Jian-zhong Xiao, Xiao-Yan Xing, Ju-Ming Lu, J. Weng, W. Jia, L. Ji, Z. Shan, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, J. Ge, Gang Chen, Li Chen, Xiao-Hui Guo, Z. Zhao, Qiang Li, Zhi-Guang Zhou, Zhao-Jun Yang, G. Shan, Jiang He, Wen-Ying Yang

BMJ Open

DOI

2013

Correction: Association of Genetic Variants with Isolated Fasting Hyperglycaemia and Isolated Postprandial Hyperglycaemia in a Han Chinese Population

Xiao-Mu Kong, Jing Hong, Ying Chen, Li Chen, Z. Zhao, Qiang Li, J. Ge, Gang Chen, Xiao-Hui Guo, Ju-Ming Lu, J. Weng, W. Jia, L. Ji, Jian-zhong Xiao, Z. Shan, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, Zhi-Guang Zhou, G. Shan, Wen-Ying Yang

PLoS ONE

DOI

2013

Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables

L. Ji, Ju-Ming Lu, Xiao-hui Guo, Wen-ying Yang, Jian-Ping Weng, Wei Jia, Da-jin Zou, Zhi-Guang Zhou, De-Min Yu, Jie Liu, Z. Shan, Yu-Zhi Yang, Ren-ming Hu, Da-Long Zhu, Li-Yong Yang, Li Chen, Zhi-Gang Zhao, Qi-Fu Li, H. Tian, Q. Ji, Jing Liu, J. Ge, Li-Xin Shi, Yan-Cheng Xu

BMC Public Health

DOI

2013

Impact of Waist Circumference and Body Mass Index on Risk of Cardiometabolic Disorder and Cardiovascular Disease in Chinese Adults: A National Diabetes and Metabolic Disorders Survey

Xu-Hong Hou, Ju-Ming Lu, J. Weng, L. Ji, Z. Shan, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, J. Ge, Li-xiang Lin, Li Chen, Xiao-Hui Guo, Z. Zhao, Qiang Li, Zhi-Guang Zhou, G. Shan, Zhao-Jun Yang, Wen-Ying Yang, W. Jia

PLoS ONE

DOI

2012

青藤碱透皮贴剂定位给药传递能力的评价

奚宏磊，杨永钢，刘婕，方亮

《沈阳药科大学学报》

DOI

2012

Serum Lipids and Lipoproteins in Chinese Men and Women

Wen-Ying Yang, Jian-zhong Xiao, Zhao-Jun Yang, L. Ji, W. Jia, J. Weng, Ju-Ming Lu, Z. Shan, Jie Liu, H. Tian, Q. Ji, Da-Long Zhu, J. Ge, Li-xiang Lin, Li Chen, Xiao-Hui Guo, Z. Zhao, Qiang Li, Zhi-Guang Zhou, G. Shan, Jiang He

Circulation

DOI

2012

Glycaemic control in patients with type 2 diabetes treated with oral antidiabetic drugs in urban areas of China

Ju-Ming Lu, L. Ji, Xiao-Hui Guo, Wen-Ying Yang, J. Weng, W. Jia, D. Zou, Zhi-Guang Zhou, De-Min Yu, Jie Liu, Z. Shan, Yu-Zhi Yang, R. Hu, Da-Long Zhu, Li-Yong Yang, Li Chen, Zhi-Gang Zhao, Qi-Fu Li, H. Tian, Q. Ji, Jing Liu, J. Ge, Li-Xin Shi

DOI

2012

Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity

Wen-Ying Yang, Wen-Hui Zhao, Jian-zhong Xiao, Rui Li, Ping Zhang, K. Kissimova-Skarbek, E. Schneider, W. Jia, L. Ji, Xiao-Hui Guo, Z. Shan, Jie Liu, H. Tian, Li Chen, Zhi-Guang Zhou, Q. Ji, J. Ge, Gang Chen, J. Brown

PLoS ONE

DOI

2012

Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study.

Zhao-jun Yang, Jie Liu, J. Ge, Li Chen, Zhi-Gang Zhao, Wen-ying Yang

European Heart Journal

DOI

2012

Status of blood glucose control and treatment of type 2 diabetes in China

L. Ji, Ju-Ming Lu, Xiao-Hui Guo, Wen-Ying Yang, J. Weng, W. Jia, D. Zou, Zhi-Guang Zhou, De-Min Yu, Jie Liu, Z. Shan, Yu-Zhi Yang, R. Hu, Da-Long Zhu, Li-Yong Yang, Li Chen, Zhi-Gang Zhao, Qi-Fu Li, H. Tian, Q. Ji, J. Liu, J. Ge, Li-Xin Shi

DOI

2012

[The baseline characteristics of patients with type 2 diabetes initiating insulin detemir : the Chinese cohort from the SOLVE(TM) study].

C. Pan, L. Ji, Ju-Ming Lu, Wen-ying Yang, Zhi-Guang Zhou, Da-jin Zou, Q. Ji, P. Han, Jie Liu, Qiang Li, Ben-li Su, Yan-Bing Li, Zheng-Nan Gao, Peng-Hua Wang, Shi-Nan Yin, Yan-hu Dong, Tao Yang, K. Sun, Hong Li, X. Hong, Jing Lin, Jing-Mei Shi, Xiao-jie Yang, Hui Fang, Xiao-dong Yan

Zhonghua nei ke za zhi

2012

Glycemic control of adult patients with type 2 diabetes mellitus treated by oral antidiabetic drugs in combination with insulin in China in 2009

Xiao-Hui Guo, L. Ji, Ju-Ming Lu, Wen-Ying Yang, J. Weng, W. Jia, D. Zou, Zhi-Guang Zhou, De-Min Yu, Jie Liu, Z. Shan, Yu-Zhi Yang, R. Hu, Da-Long Zhu, Li-Yong Yang, Li Chen, Zhi-Gang Zhao, Qi-Fu Li, H. Tian, Q. Ji, Jing Liu, J. Ge, Li-Xin Shi

DOI

2011

Influence of individually nutritional intervention on eating practices of diabetic patients

Jie Liu

2010

Impact of newly recommended HbA1c-based diabetes diagnostic criteria on the prevalence of diabetes and high risk individual in clinical and community population in China.

Li Ji, Wei Liu, Jing Liu, Yan Dong, Changshan Wang, Da-Long Zhu, Qi-Fu Li, Lu-Lu Chen, Zhang Xu, H. Tian, Ning Xia, Fan Zhang, Hong Li, Jie Liu, Shan Zhong-yan, Xiao-li Yao, Su Ben-li, Zhichun Zhou, P. Feng

Chinese Medical Journal

2010

Prevalence of diabetes among men and women in China.

Wen-ying Yang, Ju-Ming Lu, Jian-Ping Weng, W. Jia, Linong Ji, Jian-Zhong Xiao, Zhongyan Shan, Jie Liu, Hao-Ming Tian, Qiu-He Ji, Da-Long Zhu, J. Ge, Li-xiang Lin, Li Chen, Xiao-hui Guo, Zhi-Gang Zhao, Qiang Li, Zhi-Guang Zhou, Guangliang Shan, Jiang He

New England Journal of Medicine

DOI

2010

Association between serum amyloid A and obesity: a meta-analysis and systematic review

Yulan Zhao, Xue-Lian He, Xuegui Shi, Chengjin M. Huang, Jie Liu, Shu-Li Zhou, C. Heng

Inflammation Research

DOI

2002

Evaluation for the Efficacy of Taizhian in Treatment of Primary Hyperlipidemia in Aged Patients

Yi-De Miao, Jie Liu, Zhi-Gang Zhao

DOI

此主页由公开资料整理，尚未经学者本人认领。